Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): A prospective cohort study by Duvignaud, A, Jaspard, M, Chukwudumebi, I, Salam, A, Horby, P

Ribavarin for treating Lassa fever: a systematic review of pre-clinical studies and implications for human dosing by Salam, AP, Duvignaud, A, Jaspard, M, Malvy, D, Carroll, M, Tarning, J, Olliaro, PL, Horby, PW

Histoire de la maladie et facteurs pronostiques de la fièvre de Lassa en zone endémo-épidémique : une étude de cohorte prospective by Duvignaud, A, Jaspard, M, Etafo, I, Serra, B, Doutchi, M, Abejegah, C, Anglaret, X, Adedosu, N, Ayodeji, O, Malvy, D

Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE) by Duvignaud, A, Jaspard, M, Etafo, IC, Serra, B, Abejegah, C, Gabillard, D, Doutchi, M, Alabi, JF, Adedokun, MA, Akinpelu, AO, Oyegunle, OO, Etafo, J, Dede, AO, Onyechi, MN, Ireneh, MU, Gbenga-Ayeni, O, Fadiminiyi, KG, Ehigbor, PI, Ouattara, E, Levy-Marchal, C, Karcher, S, N'guessan-Koffi, L, Ahyi, I, Amani, E, Diabaté, M, Siloué, B, Schaeffer, J, Augier, A, Ogbaini-Emovon, E, Salam, AP, Horby, P, Ahmed, LA, Günther, S, Adedosu, AN, Anglaret, X, Ayodeji, OO, Malvy, D